These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18578076)

  • 21. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of interferon treatment for hepatitis C.
    van Leeuwen DJ
    JAMA; 1999 Jun; 281(22):2083-4. PubMed ID: 10367810
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C Infection: A Systemic Disease.
    Younossi ZM
    Clin Liver Dis; 2017 Aug; 21(3):449-453. PubMed ID: 28689584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An emerging epidemic. Chronic hepatitis C in children.
    Butler-Simon N; Smith DJ
    Adv Nurse Pract; 1999 Oct; 7(10):42-6; quiz 47-8. PubMed ID: 10808771
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening.
    Sarpel D; Baichoo E; Dieterich DT
    Expert Rev Anti Infect Ther; 2016; 14(5):511-21. PubMed ID: 27043049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct economic burden of chronic hepatitis C virus in a United States managed care population.
    Davis KL; Mitra D; Medjedovic J; Beam C; Rustgi V
    J Clin Gastroenterol; 2011 Feb; 45(2):e17-24. PubMed ID: 20628308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic Burden of Hepatitis C Infection.
    Stepanova M; Younossi ZM
    Clin Liver Dis; 2017 Aug; 21(3):579-594. PubMed ID: 28689595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canada's fevered failure on malaria.
    Attaran A
    CMAJ; 2007 Apr; 176(9):1249, 1251. PubMed ID: 17452652
    [No Abstract]   [Full Text] [Related]  

  • 31. An investigation of the psychosocial impact of a Compensation Tribunal on women with latrogenic hepatitis C infection.
    Coughlan B; Sheehan J; Carr A; Crowe J
    Ir Med J; 2003 Mar; 96(3):73-7. PubMed ID: 12722782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of screening for chronic hepatitis C infection in the United States.
    Eckman MH; Talal AH; Gordon SC; Schiff E; Sherman KE
    Clin Infect Dis; 2013 May; 56(10):1382-93. PubMed ID: 23392392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost.
    Tandon N; Balart LA; Laliberté F; Pilon D; Lefebvre P; Germain G; Prabhakar A
    J Med Econ; 2014 Dec; 17(12):862-71. PubMed ID: 25215925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C.
    Connolly MP; Kotsopoulos N; Ustianowski A
    J Med Econ; 2018 Jan; 21(1):19-26. PubMed ID: 28830254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
    Gellad ZF; Reed SD; Muir AJ
    Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.
    Vento S
    J Viral Hepat; 2000 May; 7 Suppl 1():7-8. PubMed ID: 10866837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
    Cholankeril G; Perumpail RB; Hu M; Skowron G; Younossi ZM; Ahmed A
    Dig Dis Sci; 2016 Sep; 61(9):2505-15. PubMed ID: 27084385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic considerations.
    Jaffin JH; Champion HR; Boulanger BR
    Crit Care Clin; 1993 Oct; 9(4):765-74. PubMed ID: 8252443
    [TBL] [Abstract][Full Text] [Related]  

  • 39.  The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico.
    Méndez-Sánchez N
    Ann Hepatol; 2012; 11(4):550-1. PubMed ID: 22700637
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modeling of the financial reserves required by the livestock disease compensation fund of Lower Saxony for rebates in the course of disease outbreaks incorporating spatial restriction zones].
    Denzin N; Gerdes U
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):495-506. PubMed ID: 26697716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.